JP2000509385A5 - - Google Patents

Download PDF

Info

Publication number
JP2000509385A5
JP2000509385A5 JP1997538815A JP53881597A JP2000509385A5 JP 2000509385 A5 JP2000509385 A5 JP 2000509385A5 JP 1997538815 A JP1997538815 A JP 1997538815A JP 53881597 A JP53881597 A JP 53881597A JP 2000509385 A5 JP2000509385 A5 JP 2000509385A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997538815A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000509385A (ja
JP4283892B2 (ja
Filing date
Publication date
Priority claimed from SE9601665A external-priority patent/SE9601665D0/xx
Application filed filed Critical
Publication of JP2000509385A publication Critical patent/JP2000509385A/ja
Publication of JP2000509385A5 publication Critical patent/JP2000509385A5/ja
Application granted granted Critical
Publication of JP4283892B2 publication Critical patent/JP4283892B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53881597A 1996-04-30 1997-04-29 生物学的活性を有する組成物 Expired - Fee Related JP4283892B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601665A SE9601665D0 (sv) 1996-04-30 1996-04-30 Biologically active composition
SE9601665-4 1996-04-30
PCT/SE1997/000721 WO1997040818A1 (en) 1996-04-30 1997-04-29 Biologically active composition

Publications (3)

Publication Number Publication Date
JP2000509385A JP2000509385A (ja) 2000-07-25
JP2000509385A5 true JP2000509385A5 (cg-RX-API-DMAC10.html) 2004-12-09
JP4283892B2 JP4283892B2 (ja) 2009-06-24

Family

ID=20402417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53881597A Expired - Fee Related JP4283892B2 (ja) 1996-04-30 1997-04-29 生物学的活性を有する組成物

Country Status (12)

Country Link
US (1) US6979454B1 (cg-RX-API-DMAC10.html)
EP (1) EP0952819B1 (cg-RX-API-DMAC10.html)
JP (1) JP4283892B2 (cg-RX-API-DMAC10.html)
AT (1) ATE345777T1 (cg-RX-API-DMAC10.html)
AU (1) AU701720B2 (cg-RX-API-DMAC10.html)
CA (1) CA2251702C (cg-RX-API-DMAC10.html)
DE (1) DE69736985T2 (cg-RX-API-DMAC10.html)
ES (1) ES2276425T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332497A (cg-RX-API-DMAC10.html)
SE (1) SE9601665D0 (cg-RX-API-DMAC10.html)
WO (1) WO1997040818A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA973705B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
DK1871353T3 (da) * 2005-04-15 2011-04-04 Einstein Coll Med Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi
US9428582B2 (en) * 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2550481T3 (es) * 2007-08-16 2015-11-10 The University Of Chicago Resistencia a patógenos de plantas
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
CA2738970A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.

Similar Documents

Publication Publication Date Title
JP2001507384A5 (cg-RX-API-DMAC10.html)
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2002512727A5 (cg-RX-API-DMAC10.html)
JP2000514473A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2001501216A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2000500055A5 (cg-RX-API-DMAC10.html)
JP2000500026A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000500874A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000500912A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000510827A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000500857A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)